Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,446 total articles
Apollomics Inc., a clinical-stage biopharmaceutical company focusing on oncology therapies, announced it has regained compliance with Nasdaq's Market Value of Listed Securities requirement, resolving prior concerns over its market capitalization falling below the minimum $35 million threshold. This reinstatement secures its listing on the Nasdaq Ca…
Circle8 Group, Inc. has successfully extended two major public sector contracts in the Netherlands, with a combined annual value of approximately $20 million. These contract renewals with Waternet and De Bevelanden strengthen Circle8's recurring revenue and underscore its robust commercial momentum in 2026, following multiple other sizable contract…
Geron Corporation, a commercial-stage biopharmaceutical company focused on blood cancer treatments, announced the appointment of Chinmaya Rath as Chief Business Officer. With over 25 years of industry experience, Rath is expected to strengthen Geron's strategic initiatives and drive the global commercialization of their telomerase inhibitor product…
Rush Street Interactive (RSI) has launched its BetRivers online casino and sportsbook platform in Alberta, Canada, extending its award-winning and highly rated gaming offerings to a new regulated market. The company aims to deliver premium entertainment and innovative gamified features to Alberta players, complementing its presence in multiple U.S.…
Kratos Defense & Security Solutions has secured an approximate $100 million sole source prime contract to produce a ground-based modular space domain awareness system. The award reflects Kratos' leadership and innovative capabilities in space domain awareness and related national security technologies, positioning the company to play a critical rol…
Sports Entertainment Gaming Global Corporation (SEGG Media) successfully executed a high-impact Quadrant x Shopify pop-up event during the 2026 British Grand Prix week in London, attracting over 10,000 fans and generating strong direct-to-consumer merchandise sales. The activation showcased SEGG's ability to convert digital audiences into multiple …
Enphase Energy announced the rollout of its IQ9N Microinverters, featuring gallium nitride (GaN) technology, in the Australian and New Zealand residential solar markets. These microinverters support high-power solar panels, offer up to 97.95% efficiency, and come with a 25-year warranty. They are compatible with existing Enphase systems and designe…
Qorvo has been recognized by Northrop Grumman with the 2026 Supplier Excellence Award for Strategic Excellence, highlighting its critical role in providing high-performance RF solutions for next-generation defense systems including aircraft, missile defense, and space platforms. This award underscores the strong strategic partnership between Qorvo …
Aligos Therapeutics announced the completion of enrollment for its global Phase 2 B-SUPREME study testing pevifoscorvir sodium as a treatment for chronic hepatitis B virus (HBV) infection. The study includes both HBeAg positive and negative participants and compares pevifoscorvir monotherapy against tenofovir disoproxil fumarate. Topline safety and…
PMGC Holdings Inc.'s subsidiary, NorthStrive Defense Tech, has executed a definitive exclusive license agreement with Florida State University Research Foundation for a patented multi-domain drone payload technology that operates across air and water environments. The license grants worldwide rights to develop and commercialize this technology, tar…
Autonomix Medical, a U.S.-based medical device company specializing in precision nerve-targeted treatments, announced the grant of a Canadian patent for its endoscopic sympathectomy systems and methods. This latest patent, part of a broader IP portfolio including U.S. and European patents, covers real-time nerve sensing, mapping, and closed-loop ne…
Cognition Therapeutics, a clinical-stage biopharmaceutical company listed on Nasdaq as CGTX, announced that CEO Lisa Ricciardi will participate in a fireside chat at the B. Riley Mind, Muscle & Vision Summit to discuss the company's ongoing START Phase 2 study and plans for initiating a Phase 3 registrational trial of their lead candidate, zervimes…
Longeveron Inc. announced new analyses from its Phase 2a trial of laromestrocel, a stem cell therapy for mild Alzheimer's disease, revealing significant reduction in neuroinflammation and brain atrophy as measured by free water MRI. The therapy showed correlations with improved clinical outcomes and blood biomarker changes. Laromestrocel has FDA RM…
Ocugen, Inc. announced a binding term sheet with Roots Pharmaceutical and Al-Dhow International Holding for the exclusive rights to develop and commercialize OCU400, a modifier gene therapy for Retinitis Pigmentosa, in the Middle East and North Africa. The deal includes up to $4 million in upfront and near-term development payments, potential $255 …
Tonix Pharmaceuticals announced a major managed Medicare payer agreement effective in 2027, adding around 9 million Medicare lives to the coverage of TONMYA®, its FDA-approved fibromyalgia treatment. Combined with prior commercial and Medicaid agreements, TONMYA's pharmacy coverage will reach approximately 46% of covered U.S. lives. In response, To…
CoreCivic, a leading government-solutions company, has declared its intention to redeem in full its outstanding $250 million 4.750% senior notes due in 2027 on August 12, 2026. The redemption will be funded using cash on hand at a price including principal, a make-whole premium, and accrued interest. This action reflects CoreCivic's management of i…
Plug Power announced two transactions with Stream Data Centers involving the sale of its Graham, Texas Project and a staged closing of its New York Gateway Project. These deals are part of Plug Power's broader strategic initiative aimed at improving liquidity by over $275 million through asset monetization, cash collateral release, and maintenance …
Kamada Ltd. announced new Investigator-Initiated Study results presented at the 2026 ISHLT Annual Meeting showing that CYTOGAM, their cytomegalovirus immune globulin product, is associated with improved clinical outcomes in high-risk lung transplant recipients. The study indicates CYTOGAM not only controls CMV viremia but may also modulate the immu…
First Hawaiian, Inc. (NASDAQ: FHB) announced it will acquire TriCo Bancshares (NASDAQ: TCBK) in an all-stock transaction, creating the 6th largest bank headquartered in the Western U.S. The combined entity will have approximately $34 billion in assets, expanding First Hawaiian's presence on the U.S. mainland. Preliminary second quarter 2026 financi…
Adlai Nortye, a clinical-stage biotechnology company listed on NASDAQ, has expanded its Scientific Advisory Board by appointing two eminent medical oncologists, Dr. David S. Hong and Dr. Piro Lito. This move aims to enhance the company's expertise and guidance in advancing its pipeline of innovative cancer therapies focused on RAS pathway targeted …
Wrap Technologies, a Nasdaq-listed public safety technology company, opened Q3 2026 with $1.2 million in international orders from Brazil and India, indicating strong demand for its non-lethal BolaWrap® 150 device. Following a landmark ruling by the ATF reclassifying BolaWrap® as an instrument of restraint rather than a firearm, the company expects…
Hillman Solutions Corp. disclosed plans to refinance its existing Term Loan B and asset-based revolving credit facility with new longer-maturity debt, aiming to extend debt maturities and improve financial flexibility. The company preliminarily reported Q2 2026 net sales growth of 9% to 10% over last year and growth in operating income and adjusted…
One year after acquiring The Shyft Group and listing on NASDAQ, Aebi Schmidt Group reports successful integration, increased synergy targets, new product launches, expanded operations, and strategic partnerships. The company outlines ambitions to surpass $3 billion in annual revenue and achieve mid-teen adjusted EBITDA margins by 2030, driven by re…
VERAXA Biotech AG announced a strategic collaboration with Ardigen to integrate AI-driven computational tools into its BiTAC® platform development. This partnership aims to optimize target selection for their novel cancer therapies, including bispecific T cell engagers and antibody drug conjugates, potentially improving safety and efficacy by reduc…
EyePoint, Inc. appoints eminent retina specialist Dr. Tarek S. Hassan as Chief Strategic Science Officer to guide strategic development and commercialization efforts, particularly for its lead investigational retinal therapy DURAVYU. The appointment comes as the company anticipates topline Phase 3 trial results for wet age-related macular degenerat…
